Introduction
In clinical application of blood pumps, thrombus formation occurs as an adverse event and causes failure of devices and thromboembolism [1] . This thrombus formation is a result of the interaction of blood, flow and surface material, which is also known as Virchow's Triad [2] . Designs of blood pumps consider this triad by the proper choice of flow and surface material. The suitability of a material is assessed by hemocompatibility tests. Diverse tests are used each having its specific strength and weakness. In some test material samples are exposed to platelet rich plasma for a certain period and attached platelets are quantified [3] . In other tests blood flows over the material sample in a more or less defined manner. In some tests, the blood circulates and passes the sample several times. To keep the circulation running different methods are used, but they strain blood components, which may result in a change of the blood properties, e.g. more activated platelets and blood damage [5] . Here, we present an approach using stagnation point flow for hemocompatibility test under controlled flow conditions, which avoids the mentioned disadvantages.
Methods
Blood: From healthy and properly informed donors, blood is drawn gently by venipuncture of the antecubital vein into citrate S-Monovettes® (sodium citrate: final concentration 10.6 mM; Sarstedt AG&Co, Nümbrecht, Germany). The first 2 ml sample is analysed and discharged. Only the following blood samples were used. Platelet rich plasma was separated by centrifugation at 120g for 20 min, dyed with in DMSO dissolved calcein red-orange AM (10µg/ml PRP; Life Technologies GmbH, Darmstadt, Germany), stored in dark at room temperature for an hour. After that, the plasma is rejoined with the remained blood part. This prepared blood is used within 3 hours after venipuncture for the experiments.
Flow chamber. The chamber is build up of an upper and a lower part, separated by a silicon gasket and a cover glass sheet. The cover glass (Corning Inc. -life science, #2940-245, Corning, New York, USA ) can be coated with a transparent layer of a test material. We used Carbothane, Pellethane (Lubrizol Co., Wickliffe, USA), von Willebrand factor (vWF) (1 Unit active protein/ml; CSL Bering GmbH, Hattersheim am Main, Germany), and native glass as test surfaces. The upper part is made out of acrylic polymer with a hollow needle of 0.65 mm inner diameter in the centre ( Fig. 1 ) and a 3 mm wide annular groove at a radius of 8.5 mm. Into the cavity of the lower part, the cover glass, the gasket, and the upper part are stacked. So, the upper part is separated by the gasket from the coated cover glass and these form an axial-symmetric 0.480 µm gap. The central orifice of the hollow needle is the inlet and the annular groove around the gap provides an outlet.
Method: A syringe pump (KDS Legato 210; KD Scientific Inc., Holliston, MA), attached at the chamber outlet, draws the prepared blood with a flow rate of 18, 36 and 72 ml/h from a reservoir, through tubes, a micro static mixer, and the chamber. In the mixer adenosine diphosphate (ADP) Figure 1 : Experimental set-up. Blood with dyed platelets is drawn into a micro static mixer to add adenosine diphospahte for platelet activation. This mixture enters the chamber through a hollow needle, hits the test surface, and is radial diverted. It flows towards an annular groove into a outlet. (11.7 µM; SERVA Electrophoresis GmbH, Heidelberg, Germany) is added to the flow in a volume ratio of 1 part ADP to 9 parts of blood before entering the chamber. After leaving the orifice of the hollow needle, blood flow creates a stagnation point at the test surface in the gap centre and discharges through the gap. Computational fluid dynamics (CFD) simulations show first a raise of the wall shear rate to a maximal value and subsequent decrease further outward. Platelet depositions were observed continuously with fluorescent video microscopy. For fluorescence stimulation, light is coupled into the light path of a microscope. A camera captured images at a resolution with an isotropic pixel size of 0.72 µm. To achieve a wider field of view the chamber is mounted in a motorized x-y-stage and 3x3 images were merged to an image of 2496 x 1872 pixel at one frame per 4 seconds. To visualize the growth of the aggregates, the images were segmented. For each pixel, the time of first platelet adherence was determined and with this data, a colourcoded image of first adherence was generated.
Results
A typical development is shown in Fig. 2 . Single platelets deposit on the test surface and form the nucleus for the later growing aggregates (Fig. 2a) . The shapes of these aggregates are elongated in flow direction. Usually the stagnation point stays free of platelet deposition. This development was observed, on the native glass, as well as on the Carbothane, vWF and Pellethane coatings. One exception of this was a sample of a polyglycerol from Prof. Haag (Free University Berlin), that showed no adhesion of single platelets. From the first mentioned tested surfaces formation of larger aggregates are observed in the further development (Fig. 2b) . In later stages of the test runs, aggregates can wash away (Fig.  2c) . This event occurred usually on the native glass surface. Aggregates attached on the vWF, Carbothane and Pellethane surfaces have shown better adherence and can resist the flow forces. Another way to show the growth of the aggregates is the sequence of adherence (Fig. 3) . It shows that newly deposited platelets preferably do so downstream of previous aggregates. In the color coded image the latest platelets are coded in deep blue and are always positioned downstream of the earlier platelets -coded in red. The direction of flow in the cutout image Fig. 3 right, is from the lower left to the upper right corner. In this manner aggregates join with others and build large coherent structures.
Discussion
With the presented method, the platelet deposition can be studied by independent variation of all three components of Virchow's triad. The blood properties are changed, also during a test run, by adding an antagonist, in our case ADP. The flow is adjusted by a proper choice of inlet flow rate or by trip struts on the surface. The sample surface is exchanged by changing the cover glass sheet with different coating. In comparison to other tests, blood -one component of the triad -is subjected to minimal stress. Owing to the single passage, blood properties at the inflow keep constant during a test run. Human blood can be used easier owing to the small amount of blood needed. In this way, dependant on the species can be avoided [5] . The flow -the second component of the triad -creates different wall shear rates on the test surface. Therefore, regions with high and low convective blood transport towards the walls are formed, which are comparable to the in vivo situation. Furthermore, the flow is undisturbed during a test run and only effected by the formed aggregates. The test material -the third component of the triad -must be applied as transparent layer on the cover glass. This is the main limitation of this approach, but it can be applied for most of the materials, which are polymers and transparent in thin layers. Without that limitation, two or more materials can be compared at once. For this purpose, the materials are coated in different sectors around the centre. This allows a direct comparison between two materials at the same experimental conditions without interdependence. In addition, test runs with structured surfaces are possible to generate. The direct observation of the process of deposition reveals mechanisms like thrombus formation, which may be missed by other tests. When only platelet deposition is assessed after a test run, a material may be misjudged.
In addition to the mentioned potentialities, a further development could be to use a three-dimensional scanning microscope to obtain the volumetric size of the depositions.
